The Sex-Dimorphic Paradox of Hepatic Steatosis

The sex-dimorphic paradox of hepatic steatosis refers to the phenomenon where opposite extremes of testosterone levels drive the exact same metabolic dysfunctions in men and women. Specifically, hypogonadism (low testosterone) in men and hyperandrogenism (excess testosterone) in women both exacerbate the risk and severity of hepatic steatosis (fatty liver) and metabolic syndrome.Normal Sex Differences in Metabolism Men and women naturally display significant differences in energy partitioning and lipid homeostasis. In women, estrogens promote the accumulation of subcutaneous fat (typically in the gluteal and femoral regions) and protect against insulin resistance. In contrast, men are more prone to accumulating visceral (abdominal) fat, which is metabolically active and easily releases free fatty acids into the liver—a primary driver of hepatic triglyceride accumulation.The Paradox in Men: Low Testosterone In men, testosterone deficiency is closely associated with increased visceral adiposity, reduced lean muscle mass, and worsening insulin resistance. This forms a vicious cycle: excess visceral fat increases the conversion (aromatization) of androgens into estradiol, which suppresses the hypothalamic–pituitary–gonadal axis and drops testosterone levels even further. Consequently, lower testosterone levels in men are an independent risk factor for developing hepatic steatosis, and testosterone replacement therapy has been shown to reduce liver fat and improve cardiometabolic profiles in hypogonadal men.The Paradox in Women: High Testosterone & Low Estrogen Conversely, women who experience hyperandrogenism—most commonly due to Polycystic Ovary Syndrome (PCOS)—face a significantly increased risk of developing hepatic steatosis. In women, excess testosterone inhibits the normal proliferation of fat cells, forcing existing adipocytes to become hypertrophic (enlarged) and dysfunctional. This leads to local inflammation, insulin resistance, and a shift in fat distribution from the hips and thighs to the highly detrimental visceral abdominal cavity.Furthermore, estrogen deficiency (such as during menopause) removes the hormone's protective metabolic effects. 17-β estradiol normally protects the liver by reducing gluconeogenesis, limiting de novo lipogenesis, and promoting fatty acid oxidation. When estrogen levels fall, women experience increased central adiposity, dyslipidemia, and a substantially higher risk of hepatic steatosis and cardiovascular disease.Ultimately, maintaining systemic homeostasis and protecting the liver relies heavily on sex-specific hormonal balance, as both an excess of androgens in females and a deficiency of androgens in males result in severe metabolic deterioration